Eureka Eurostars: Grant Funding Available for Transnational Innovation Projects
Eureka Eurostars is the largest international funding programme for SMEs wishing to collaborate on transnational innovation projects. It supports research-performing SMEs with research and development to help them gain a competitive advantage; their project results are then rapidly commercialised. Funding for UK SMEs is through Innovate UK. They will cover up to 60% of project costs through grant funding, with a maximum of €360,000 allowed per project
Eurostars in Numbers
According to the Eureka website, 29% of applications receive funding. Significantly, 45% of participants have been successful in reaching new markets, while 84% of project partners form long-term relationships.
Eligibility Criteria
The main eligibility criteria are as follows:
- Firstly, research institutes, universities and large enterprises can participate. However, the project lead must be an R&D-performing SME from a Eurostars country.
- Projects must have a civilian purpose.
- The consortium must include at least two partners independent from each other and established in at least two different Eurostars countries.
- Lastly, you must complete the project in less than 36 months. The Eurostars project market introduction of the project results should be within 24 months of the completion of the project.
How Can RedKnight Help?
RedKnight has an excellent track record with supporting applications to Eureka Eurostars. Most recently, we won €578,684 on behalf of Thermetrix Ltd and €345,566 for the REDEEMA consortia. You can read more about each of these on our projects page. For further information on the Eureka Eurostars programme, please visit their website. If you would like our support with an application, contact us today to arrange a free consultation.
Sign up for our free monthly newsletter to receive grant funding opportunities direct to your inbox.
Innovative medical imaging camera project led by Thermetrix awarded over €578k from Eureka-Eurostars
RedKnight is delighted to have supported South Wales based start-up, Thermetrix Ltd, with a successful application to the Eureka Eurostars programme. Since 2017, Thermetrix have designed and manufactured hardware and software for medical devices in personal healthcare. The company, along with two SME partners, Quantificare (France) and SymblCrowd (Germany), will now receive €578, 684 in grant funding to develop its Multi-Modal Medical Mapper (M4).
Aims
M4 aims to deliver a prototype of a portable camera that integrates 3D scanning, visual and (thermal) infrared imaging modalities. As the user moves the camera along the human body under investigation, it will capture and display the three representational characteristics in a single 3D representation. During the scanning process, graphical overlays will adaptively guide the user. This will minimise the amount of training required and improve the reliability and repeatability of scans.
The project is disruptive in the digital medical devices sector as there are no existing devices capable of performing all functions at the same time. Therefore, this device opens entirely new possibilities for prevention, diagnosis, and treatment, in areas including Diabetic Foot Ulcer treatment, medical aesthetics and wound healing. Importantly, M4 addresses a pressing need for more accurate, reliable devices for wound measurement and management of higher practicality. It will also be usable by all healthcare professionals in various settings and at commoditised price points.
Outcomes
Combined, the global Diabetic Foot Ulcer, Wound Care Management and Medical Aesthetics markets are worth $53.77bn. They pose significant socio-economic challenges to both patients and healthcare systems worldwide. With anticipated high reliability and accuracy, M4 could reduce costs by 13%, saving the EU over $1 billion each year. Crucially, M4 could also save patient lives and improve quality of life for many.
Dr Peter Plassmann, Founder and CEO at Thermetrix said of the success,
“It would have been impossible for us to navigate the complex and time-consuming Eurostars application process on our own. The support from RedKnight was crucial for the success in this highly competitive competition. ”
You can read about more of our recent success stories here. If you would like to discuss your own project with one of our expert advisers, please contact us today.
REDEEMA Awarded €345,566 from Eureka Eurostars
RedKnight is delighted to celebrate its 5th birthday with another grant funding success story! A successful application to Eureka Eurostars has secured €345,566 for the South Wales-based Compound Semiconductor Centre Ltd and its partners. The REDEEMA consortium also includes Glasgow-based Amethyst Research Ltd and VTEC Lasers & Sensors, based in Eindhoven.
The project, titled REsonant cavity DEtectors for Environmental Monitoring Applications (REDEEMA), aims to design and develop an inexpensive manufacturable (III-V semiconductor material based) resonant cavity enhanced photodiode (RCE-PD) infrared (IR) sensing array for monitoring greenhouse gases (GHGs), such as carbon dioxide, methane, and nitrous oxide. A paradigm in high sensitivity mid-IR GHG sensing, the REDEEMA sensor will aid existing analytical instrumentation in the intelligent field deployment of the quantitative analysers and in the determination of gas sources.
Many chemical compounds in the earth’s atmosphere act as GHGs, including water vapour, carbon dioxide, and methane. The percentage of environmentally significant trace gases is rising due to increased human activity. There is a critical need to track these changes to monitor the extent of global changes in the GHG composition of the atmosphere. It is also crucial to actively identify the sources of these emissions so that action can be taken to mitigate and effectively manage the releases.
In this regard, Amethyst's RCE-PD incorporates a unique and revolutionary design, which will be used in the development of next-generation IR detectors capable of meeting the demands of a vast range of applications. The resulting gas-detection system developed through REDEEMA will significantly improve performance over nearest state-of-the-art IR detectors, opening many new opportunities with environmental applications.
Dr. Wyn Meredith, Director at CSC, said of the successful application:
“The Redknight team supported our proposal by taking ownership of the specific requirements of the Eurostars application process, allowing our own staff to focus on the essence of the technical and commercial proposition. This accelerated the development of the bid and ultimately was a key factor in a successful outcome in a highly competitive process.”
Helping companies grow is RedKnight's core mission. For our assistance in putting together a competitive proposal for your business, contact us today.